Detailed view for Chro.60177

Basic information

TDR Targets ID: 364860
Cryptosporidium hominis, cdc2-related protein kinase
Source Database / ID: 

pI: 9.7656 | Length (AA): 664 | MW (Da): 77550 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00069   Protein kinase domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0005524   ATP binding  
GO:0004672   protein kinase activity  
GO:0006468   protein amino acid phosphorylation  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 4 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
10 608 4kik (B) 15 604 17.00 0.000000000012 1 0.912108 0.3
16 348 4nst (C) 733 1033 42.00 0 1 0.798806 -0.06
485 558 5hhe (D) 189 262 19.00 0 0.03 0.761746 -5.36
486 546 5d23 (A) 130 186 18.00 0 0 0.586167 -4.63

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

No expression data available for this gene

Orthologs

Ortholog group members (OG5_135486)

Species Accession Gene Product
Babesia bovis BBOV_I001950   protein kinase domain containing protein
Cryptosporidium hominis Chro.60177   cdc2-related protein kinase
Cryptosporidium parvum cgd6_1420   cdc2-related protein kinase, putative
Leishmania braziliensis LbrM.27.2100   protein kinase-like protein
Leishmania donovani LdBPK_271860.1   cdc2-related kinase 9
Leishmania infantum LinJ.27.1860   protein kinase-like protein
Leishmania major LmjF.27.1940   protein kinase-like protein
Leishmania mexicana LmxM.27.1940   protein kinase-like protein
Neospora caninum NCLIV_065460   CMGC kinase, putative
Plasmodium berghei PBANKA_0717300   cdc2-related protein kinase 3
Plasmodium falciparum PF3D7_0415300   cdc2-related protein kinase 3
Plasmodium knowlesi PKNH_0506900   protein kinase, putative
Plasmodium vivax PVX_089720   protein kinase domain containing protein
Plasmodium yoelii PY04026   cdc-2 related kinase 3
Trypanosoma brucei gambiense Tbg.972.2.2560   protein kinase, putative
Trypanosoma brucei Tb927.2.4510   cdc2-related kinase 9
Trypanosoma congolense TcIL3000_2_850   cdc2-related kinase 9
Trypanosoma cruzi TcCLB.507209.40   cdc2-related kinase 9
Trypanosoma cruzi TcCLB.509099.150   cdc2-related kinase 9
Toxoplasma gondii TGME49_249260   cell-cycle-associated protein kinase CDK, putative
Theileria parva TP03_0140   cell division cycle 2 protein kinase, putative

Essentiality

Chro.60177 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
Tb927.2.4510 Trypanosoma brucei significant loss of fitness in bloodstream forms (3 days) alsford
Tb927.2.4510 Trypanosoma brucei significant loss of fitness in bloodstream forms (6 days) alsford
Tb927.2.4510 Trypanosoma brucei significant loss of fitness in procyclic forms alsford
Tb927.2.4510 Trypanosoma brucei no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms alsford
PBANKA_0717300 Plasmodium berghei Essential plasmo
TGME49_249260 Toxoplasma gondii Essentiality uncertain sidik
Show/Hide essentiality data references
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
Species Target Length Identity Alignment span Linked Drugs Reference
Plasmodium falciparum (isolate 3D7) Cell division control protein 2 homolog 288 aa 34.6% 335 aa Compounds References
Bos taurus Glycogen synthase kinase-3 beta splice variant X1 419 aa 27.4% 390 aa Compounds References
Oryctolagus cuniculus Cyclin-dependent kinase 4 189 aa 36.4% 195 aa Compounds References
Rattus norvegicus MAP kinase p38 alpha 360 aa 30.8% 334 aa Compounds References
Homo sapiens Cyclin-dependent kinase 1/cyclin B1 297 aa 34.9% 332 aa Compounds References
Rattus norvegicus Mitogen-activated protein kinase 1 358 aa 30.8% 351 aa Compounds References
Rattus norvegicus Mitogen-activated protein kinase 8 411 aa 28.6% 357 aa Compounds References
Sus scrofa Glycogen synthase kinase 3 beta 420 aa 27.4% 390 aa Compounds References
Patiria pectinifera Cdc2 300 aa 35.7% 345 aa Compounds References
Xenopus laevis Aurora kinase B-A 361 aa 27.0% 326 aa Compounds References
Rattus norvegicus Glycogen synthase kinase-3 beta 420 aa 27.4% 390 aa Compounds References
Xenopus laevis Aurora kinase B-B 368 aa 26.7% 326 aa Compounds References
Rattus norvegicus Cell division protein kinase 5 292 aa 35.2% 335 aa Compounds References
Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Chro.60177 (Cryptosporidium hominis), cdc2-related protein kinase
Title for this comment
Comment